ACTINOGEN MEDICAL LIMITEDACTINOGEN MEDICAL LIMITEDACTINOGEN MEDICAL LIMITED

ACTINOGEN MEDICAL LIMITED

No trades
See on Supercharts

ACW fundamentals

Key facts

Market capitalization
Founded
CEO
Website
About

Actinogen Medical Ltd. is a clinical stage Australian biotechnology company, which focuses on the development of novel treatments or cognitive impairment associated with neurological, psychiatric, and metabolic diseases due to raised cortisol. The company was founded by Geoff E. D. Brooke & David Keast on March 23, 1999 and is headquartered in Sydney, Australia.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
No data available
There's currently no market capitalization, revenue or net income data to show.
Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

No dividends
ACW has never paid dividends and has no current plans to do so.

Financial health

Financial position and solvency of the company